ArticleBriefings in bioinformatics2025
BloodProST: prediction of blood-secretory proteins through self-training.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate identification of proteins secreted into the bloodstream is essential for discovering diagnostic biomarkers and therapeutic targets. A significant challenge is the scarcity of experimentally validated blood-secretory proteins, limiting labeled datasets required for robust model training. To address this issue, we propose BloodProST, a novel machine-learning framework leveraging a self-training strategy to reliably predict blood-secretory proteins. BloodProST iteratively expands the labeled dataset by generating high-confidence pseudo-labels from a large pool of unlabeled protein sequences, thereby progressively enhancing model predictions without continuous manual annotation. At its core, BloodProST incorporates an unsupervised feature selection module based on differential evolution, optimizing the Silhouette score to identify the most discriminative physicochemical and sequence-derived features. Additionally, BloodProST employs a dual-pathway convolutional neural network and long short-term memory (CNN)-(LSTM) architecture: a CNN-based pathway captures local information from pre-constructed features, whereas an LSTM-based pathway extracts high-level sequential dependencies directly from protein sequences. Furthermore, domain-specific biological priors, such as the expected proportion of secretory proteins, are integrated into the model's loss function to guide training toward biologically plausible predictions. Extensive evaluation demonstrates that BloodProST significantly outperforms 14 state-of-the-art models across multiple metrics, achieving superior predictive accuracy, robustness, and interpretability. Validation analyses confirm the biological relevance of predictions through secretion-related markers (e.g. signal peptides and transmembrane regions) and demonstrate effective generalization to other biofluids, such as urine. Collectively, these results illustrate BloodProST's potential as a versatile computational tool for secretion prediction and biomarker discovery across diverse biological fluids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.